Terns Pharmaceuticals Inc (TERN)
6.14
+0.15
(+2.50%)
USD |
NASDAQ |
May 16, 16:00
6.145
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Cash and Short Term Investments (Quarterly): 240.65M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 240.65M |
| December 31, 2023 | 263.44M |
| September 30, 2023 | 266.60M |
| June 30, 2023 | 285.60M |
| March 31, 2023 | 297.53M |
| December 31, 2022 | 283.11M |
| September 30, 2022 | 187.29M |
| June 30, 2022 | 139.81M |
| Date | Value |
|---|---|
| March 31, 2022 | 151.27M |
| December 31, 2021 | 165.98M |
| September 30, 2021 | 177.20M |
| June 30, 2021 | 185.08M |
| March 31, 2021 | 195.58M |
| December 31, 2020 | 74.85M |
| September 30, 2020 | 13.76M |
| December 31, 2019 | 19.65M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
13.76M
Minimum
Sep 2020
297.53M
Maximum
Mar 2023
184.21M
Average
186.18M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Viking Therapeutics Inc | 962.98M |
| Eli Lilly and Co | 2.586B |
| Pfizer Inc | 11.93B |
| Amgen Inc | 9.708B |
| Madrigal Pharmaceuticals Inc | 1.059B |